MoneyWorks4Me

Piramal Pharma - Quaterly Results

08 Nov 2022 Evaluate
With no major difference for the quarter endedSeptember 2022 , the total revenue stood at Rs. 8288.70  millions.The Company to register a -48.11%  fall in the net profit for the quarter ended September 2022.The Operating Profit of the company witnessed a decrease to 1645.30 millions from 1717.60 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202209 202109 % Var
Sales 8288.70 8026.20 3.27 8288.70 8026.20 3.27 8288.70 8026.20 3.27
Other Income 1177.00 609.00 93.27 1177.00 609.00 93.27 1177.00 609.00 93.27
PBIDT 1645.30 1717.60 -4.21 1645.30 1717.60 -4.21 1645.30 1717.60 -4.21
Interest 285.60 151.10 89.01 285.60 151.10 89.01 285.60 151.10 89.01
PBDT 1290.10 1566.50 -17.64 1290.10 1566.50 -17.64 1290.10 1566.50 -17.64
Depreciation 471.10 375.40 25.49 471.10 375.40 25.49 471.10 375.40 25.49
PBT 819.00 1191.10 -31.24 819.00 1191.10 -31.24 819.00 1191.10 -31.24
TAX 345.70 278.90 23.95 345.70 278.90 23.95 345.70 278.90 23.95
Deferred Tax 244.50 18.70 1207.49 244.50 18.70 1207.49 244.50 18.70 1207.49
PAT 473.30 912.20 -48.11 473.30 912.20 -48.11 473.30 912.20 -48.11
Equity 11933.20 9946.00 19.98 11933.20 9946.00 19.98 11933.20 9946.00 19.98
PBIDTM(%) 19.85 21.40 -7.24 19.85 21.40 -7.24 19.85 21.40 -7.24
Peers
Company Name CMP
Sun Pharma. Inds. 1846.80
Dr. Reddys Labs. 1228.60
Cipla 1390.60
Lupin 2069.80
Zydus Lifesciences 1216.00
View more..